vs

Side-by-side financial comparison of CARLISLE COMPANIES INC (CSL) and STEPAN CO (SCL). Click either name above to swap in a different company.

CARLISLE COMPANIES INC is the larger business by last-quarter revenue ($1.1B vs $604.5M, roughly 1.7× STEPAN CO). CARLISLE COMPANIES INC runs the higher net margin — 12.1% vs 3.3%, a 8.9% gap on every dollar of revenue. On growth, STEPAN CO posted the faster year-over-year revenue change (1.9% vs -4.0%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs -14.8%).

Carlisle Companies Incorporated is a supplier of construction products that make buildings more energy efficient and resilient. The company manufactures and sells single-ply roofing products as well as warranted systems and accessories for the commercial building industry. The company is organized into two segments, including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing unde...

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

CSL vs SCL — Head-to-Head

Bigger by revenue
CSL
CSL
1.7× larger
CSL
$1.1B
$604.5M
SCL
Growing faster (revenue YoY)
SCL
SCL
+5.9% gap
SCL
1.9%
-4.0%
CSL
Higher net margin
CSL
CSL
8.9% more per $
CSL
12.1%
3.3%
SCL
Faster 2-yr revenue CAGR
SCL
SCL
Annualised
SCL
4.2%
-14.8%
CSL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CSL
CSL
SCL
SCL
Revenue
$1.1B
$604.5M
Net Profit
$127.7M
$19.7M
Gross Margin
34.5%
10.7%
Operating Margin
17.1%
4.7%
Net Margin
12.1%
3.3%
Revenue YoY
-4.0%
1.9%
Net Profit YoY
-10.9%
EPS (diluted)
$3.10
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSL
CSL
SCL
SCL
Q1 26
$1.1B
$604.5M
Q4 25
$1.1B
$553.9M
Q3 25
$1.3B
$590.3M
Q2 25
$1.4B
$594.7M
Q1 25
$1.1B
$593.3M
Q4 24
$1.1B
$525.6M
Q3 24
$1.3B
$546.8M
Q2 24
$1.5B
$556.4M
Net Profit
CSL
CSL
SCL
SCL
Q1 26
$127.7M
$19.7M
Q4 25
$127.4M
$5.0M
Q3 25
$214.2M
$10.8M
Q2 25
$255.8M
$11.3M
Q1 25
$143.3M
$19.7M
Q4 24
$162.8M
$3.4M
Q3 24
$244.3M
$23.6M
Q2 24
$712.4M
$9.5M
Gross Margin
CSL
CSL
SCL
SCL
Q1 26
34.5%
10.7%
Q4 25
33.8%
9.3%
Q3 25
36.0%
12.0%
Q2 25
37.3%
12.1%
Q1 25
35.2%
12.7%
Q4 24
36.1%
10.8%
Q3 24
38.6%
13.8%
Q2 24
39.2%
12.5%
Operating Margin
CSL
CSL
SCL
SCL
Q1 26
17.1%
4.7%
Q4 25
16.8%
1.9%
Q3 25
21.8%
3.7%
Q2 25
23.1%
3.0%
Q1 25
16.8%
4.8%
Q4 24
19.9%
1.5%
Q3 24
23.7%
4.4%
Q2 24
26.0%
3.4%
Net Margin
CSL
CSL
SCL
SCL
Q1 26
12.1%
3.3%
Q4 25
11.3%
0.9%
Q3 25
15.9%
1.8%
Q2 25
17.6%
1.9%
Q1 25
13.1%
3.3%
Q4 24
14.5%
0.6%
Q3 24
18.3%
4.3%
Q2 24
49.1%
1.7%
EPS (diluted)
CSL
CSL
SCL
SCL
Q1 26
$3.10
$0.86
Q4 25
$3.06
$0.22
Q3 25
$4.98
$0.47
Q2 25
$5.88
$0.50
Q1 25
$3.20
$0.86
Q4 24
$3.76
$0.14
Q3 24
$5.25
$1.03
Q2 24
$14.84
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSL
CSL
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$771.3M
Total DebtLower is stronger
$328.4M
Stockholders' EquityBook value
$1.7B
$1.2B
Total Assets
$2.3B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSL
CSL
SCL
SCL
Q1 26
$771.3M
Q4 25
$1.1B
$132.7M
Q3 25
$1.1B
$118.5M
Q2 25
$68.4M
$88.9M
Q1 25
$220.2M
$107.5M
Q4 24
$753.5M
$99.7M
Q3 24
$1.5B
$147.3M
Q2 24
$1.7B
$124.7M
Total Debt
CSL
CSL
SCL
SCL
Q1 26
$328.4M
Q4 25
$2.9B
$626.7M
Q3 25
$2.9B
$655.5M
Q2 25
$1.9B
$658.0M
Q1 25
$1.9B
$659.3M
Q4 24
$1.9B
$625.4M
Q3 24
$2.3B
$688.5M
Q2 24
$2.3B
$657.1M
Stockholders' Equity
CSL
CSL
SCL
SCL
Q1 26
$1.7B
$1.2B
Q4 25
$1.8B
$1.2B
Q3 25
$2.0B
$1.2B
Q2 25
$2.1B
$1.2B
Q1 25
$2.2B
$1.2B
Q4 24
$2.5B
$1.2B
Q3 24
$2.8B
$1.2B
Q2 24
$3.0B
$1.2B
Total Assets
CSL
CSL
SCL
SCL
Q1 26
$2.3B
Q4 25
$6.3B
$2.4B
Q3 25
$6.5B
$2.4B
Q2 25
$5.5B
$2.4B
Q1 25
$5.5B
$2.4B
Q4 24
$5.8B
$2.3B
Q3 24
$6.5B
$2.4B
Q2 24
$6.7B
$2.3B
Debt / Equity
CSL
CSL
SCL
SCL
Q1 26
0.28×
Q4 25
1.61×
0.50×
Q3 25
1.45×
0.53×
Q2 25
0.89×
0.53×
Q1 25
0.87×
0.55×
Q4 24
0.77×
0.53×
Q3 24
0.83×
0.56×
Q2 24
0.76×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSL
CSL
SCL
SCL
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-73.0M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$924.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSL
CSL
SCL
SCL
Q1 26
Q4 25
$386.0M
$60.0M
Q3 25
$426.9M
$69.8M
Q2 25
$287.1M
$11.2M
Q1 25
$1.8M
$6.9M
Q4 24
$370.6M
$68.3M
Q3 24
$312.8M
$22.7M
Q2 24
$183.4M
$29.5M
Free Cash Flow
CSL
CSL
SCL
SCL
Q1 26
$-73.0M
Q4 25
$346.1M
$25.4M
Q3 25
$393.4M
$40.2M
Q2 25
$258.3M
$-14.4M
Q1 25
$-27.2M
$-25.8M
Q4 24
$334.0M
$32.1M
Q3 24
$293.5M
$-4.0M
Q2 24
$158.5M
$-208.0K
FCF Margin
CSL
CSL
SCL
SCL
Q1 26
-6.9%
Q4 25
30.7%
4.6%
Q3 25
29.2%
6.8%
Q2 25
17.8%
-2.4%
Q1 25
-2.5%
-4.3%
Q4 24
29.7%
6.1%
Q3 24
22.0%
-0.7%
Q2 24
10.9%
-0.0%
Capex Intensity
CSL
CSL
SCL
SCL
Q1 26
2.7%
Q4 25
3.5%
6.3%
Q3 25
2.5%
5.0%
Q2 25
2.0%
4.3%
Q1 25
2.6%
5.5%
Q4 24
3.3%
6.9%
Q3 24
1.4%
4.9%
Q2 24
1.7%
5.3%
Cash Conversion
CSL
CSL
SCL
SCL
Q1 26
Q4 25
3.03×
11.99×
Q3 25
1.99×
6.44×
Q2 25
1.12×
0.99×
Q1 25
0.01×
0.35×
Q4 24
2.28×
20.38×
Q3 24
1.28×
0.96×
Q2 24
0.26×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSL
CSL

Segment breakdown not available.

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons